Funding the Control Grid Part 1: The Biomedical Framework
Become a member: Subscribe
Solari’s Building Wealth materials are organized to inspire and support your personal strategic and financial planning.

Missing Money
Articles and video discussions of the $21 Trillion dollars missing from the U.S. government
No posts
Funding the Control Grid Part 1: The Biomedical Framework

by: The Sharper Edge
Agencies receiving billions of taxpayer dollars have funded research that led to the Covid bioweapon and mRNA Covid injections which have proven to be more dangerous than the virus itself. These agencies have continued to support gain-of-function research and are fast-tracking mRNA technology for other vaccines and medicines including a “universal flu vaccine.”
Congress has authorized a boost in funding through the Omnibus bill and the National Defense Authorization Act of 2023 (NDAA) for the very entities responsible for the Covid catastrophe which has plagued the world. The purpose of this report is to outline the funding of agencies that contribute to the biomedical control grid condensed from 6,000 pages of legislation rushed through Congress at the end of 2022.
Through this legislation, agencies and organizations outlined in this report are tasked with preparing for the next pandemic, developing and stockpiling more mRNA injections, scaling up surveillance tools, research and development of biotechnology, and maintaining U.S. chemical and biological defense programs.
In short, the 2023 Omnibus and NDAA will expand funding of the biomedical control grid using billions of taxpayer dollars.
Continue at Corey’s Digs here.
Related Reading:
3 Comments
Comments are closed.
Our mission is to help you live a free and inspired life. This includes building wealth in ways that build real wealth in the wider economy. We believe that personal and family wealth is a critical ingredient of both individual freedom and community, health and well-being.
Nothing on The Solari Report should be taken as individual investment, legal, or medical advice. Anyone seeking investment, legal, medical, or other professional advice for his or her personal situation is advised to seek out a qualified advisor or advisors and provide as much information as possible to the advisor in order that such advisor can take into account all relevant circumstances, objectives, and risks before rendering an opinion as to the appropriate strategy.
Be the first to know about new articles, series and events.

3 Comments
-
This information is infuriating. My only consolation is that the controllers look like morons on almost every front, and desperate morons at that. I think they’re losing their grip on hearts and minds. Thanks for shining the light
-
A pandemic czar??? Oh, the irony.
-
As quoted from Corey’s excellent article, it would be really important if in this bill it was defined exactly what these other “transactions” would be?! What the heck are they if they aren’t contracts, grants or cooperative agreements? Where is the transparency going to be avail on these other types of transactions???
“Also in Section 2001, under the CDC Director’s duties, ‘the Director may enter into transactions other than a contract, grant, or cooperative agreement for purposes of infectious disease research, biosurveillance, infectious disease modeling, and public health preparedness and response.’ “
Comments are closed.
This information is infuriating. My only consolation is that the controllers look like morons on almost every front, and desperate morons at that. I think they’re losing their grip on hearts and minds. Thanks for shining the light
A pandemic czar??? Oh, the irony.
As quoted from Corey’s excellent article, it would be really important if in this bill it was defined exactly what these other “transactions” would be?! What the heck are they if they aren’t contracts, grants or cooperative agreements? Where is the transparency going to be avail on these other types of transactions???
“Also in Section 2001, under the CDC Director’s duties, ‘the Director may enter into transactions other than a contract, grant, or cooperative agreement for purposes of infectious disease research, biosurveillance, infectious disease modeling, and public health preparedness and response.’ “